Pharmaceuticals
Customs duty exemption, GST rate cut to bring down retail prices of cancer drugs
30 Oct 2024
The maximum retail prices (MRP) of three main drugs used in the treatment of cancer, viz, Trastuzumab, Osimertinib and Durvalumab
Drug regulator finds samples of calcium supplement Shelcal 500 and antacid Pan D as spurious
27 Oct 2024
A routine inspection by the Central Drug Regulatory Authority of retail medical shops in select locations of Odisha
Merck pays $30 million upfront to acquire cancer therapy developer Modifi Biosciences
24 Oct 2024
US pharma multinational Merck has acquired Modifi Biosciences, a developer of new oncology drug molecules, for $30 million upfront and up to $1.3 billion
NPPA hikes ceiling prices of 8 essential drugs by 50%
16 Oct 2024
National Pharmaceutical Pricing Authority (NPPA) has approved a 50 per cent increase in the ceiling prices of 11 scheduled formulations of eight drugs
Novartis India refutes media reports of negotiations with Alkem Labs
27 Sep 2024
Novartis India, has refuted media reports stating that its parent company is in talks with Mumbai-based Alkem Labs for sale of the Indian arm.
Mankind Pharma to buy Bharat Serums and Vaccines in a Rs13,630-cr deal
27 Jul 2024
Mankind Pharma is acquiring Bharat Serums and Vaccines (BVS) from private equity firm Advent International in a deal valued at Rs13,630 crore.
AstraZeneca starts global recall of its controversial Covid 19 vaccine
08 May 2024
Days after admitting that its Covid 19 vaccine could cause blood clot in some people, British-Swedish pharmaceutical company AstraZeneca
Novartis to acquire US-based Mariana Oncology in $1.75 bn deal
03 May 2024
Swiss drug maker Novartis has agreed to acquire US-based Mariana Oncology in a deal worth $1.75 billion, as the company seeks advance the development of precision treatment for cancer.
Chinese industrial goods accounted for 30% of India’s 2023-24 imports: GTRI report
29 Apr 2024
China's share in India's industrial goods imports jumped to 30 per cent in 2023-24 from 21 per cent over the 15-year period between 2008-09 and 2023-24, as per a report published by Global Trade Research Initiative (GTRI).
Govt revamps technology upgradation scheme for pharma sector
13 Mar 2024
The union government on Monday announced a revamped scheme of assistance for technology upgradation in the pharmaceuticals sector – a move aimed at ensuring that Indian industries are on par with global standards.
Novartis announces strategic review of its India business
19 Feb 2024
Swiss pharma multinational Novartis AG has started a strategic review of its Indian arm, possibly with the intent of selling it off.
Taro to merge with Sun Pharma in $350 million deal
21 Jan 2024
Sun Pharmaceutical Industries Limited and Israel-based Taro Pharmaceutical Industries Ltd have entered into a definitive merger agreement under which Sun Pharma
LyondellBasell to acquire 35% of Saudi petrochemical company for $500 m
17 Jan 2024
LyondellBasell, a global leader in petrochemicals, today announced the signing of an agreement to acquire a 35 per cent interest in Saudi Arabia–based National Petrochemical Industrial Company (NATPET)
Bristol Myers Squibb to acquire RayzeBio for $4.1 billion in cash
31 Dec 2023
American multinational pharmaceutical company Bristol Myers Squibb on Tuesday said it would buy RayzeBio for about $4.1 billion to bolster its cancer drug business
AstraZeneca to buy China's Gracell Biotechnologies for $1.2 bn
27 Dec 2023
Anglo-Swedish multinational pharmaceutical and biotechnology company AstraZeneca has agreed to acquire China-based Gracell Biotechnologies Inc, for about $1.2 billion.
Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 bn
26 Dec 2023
Bristol Myers Squibb on Friday agreed to acquire Karuna Therapeutics, a pioneer in schizophrenia drugs, for $330 per share in cash
Pfizer is set to acquire Seagen for $43 billion and create a new oncology division
13 Dec 2023
In a significant move, Pfizer has announced its anticipation of concluding the $43 billion deal to acquire cancer drug maker Seagen by 16 December 2023.
Western drugmakers pivot to India as tensions with China prompt supply chain shifts
27 Nov 2023
In a strategic move to reduce dependence on Chinese contractors in drug production, global pharmaceutical companies are turning to Indian manufacturers.
Moderna sues Pfizer-BioNtech for patent violation
02 Sep 2022
According to Moderna, Pfizer-BioNTech copied mRNA technology that Moderna had patented between 2010 and 2016, well before Covid-19 emerged in 2019
Featured articles
The remarkable Ratan Tata
By Kiron Kasbekar | 23 Oct 2024
One newspaper report of Ratan Tata’s passing away showed an old photo of him climbing into the cockpit of a Lockheed Martin F-16 fighter.
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation